|
Published by: Global Markets Direct
Published: Mar. 20, 2009 - 72 Pages
Table of Contents
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of Markets Covered in This Report
- 3.1 Drug delivery devices
- 3.2 Needle-free Injections
- 3.3 Inhalation Systems
- 3.3.1 Metered Dose Inhaler
- 3.3.2 Dry powder inhaler
- 3.4 Infusion Systems
- 3.4.1 Infusion pumps
- 3.4.2 Syringe pumps
- 3.4.3 Disposable Infusion sets
- 4 Healthcare Sector Review
- 4.1 Healthcare Expenditure
- 4.2 Healthcare Infrastructure
- 4.3 Healthcare Policy
- 5 Regulation System
- 5.1 Medical Device Registration Protocol
- 5.1.1 Registration Documentation
- 5.1.2 Registration Procedure
- 5.1.3 Medical Device Registration Fee
- 6 Pricing and Reimbursement
- 7 Distribution Structure
- 8 Drug Delivery Devices In Brazil
- 8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
- 8.2 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015
- 8.3 Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015
- 8.4 Drug Delivery Devices, Brazil, Company Share (2006-2007)
- 9 Infusion Systems In Brazil
- 9.1 Infusion Systems Overall Revenue (2000-2015)
- 9.2 Infusion Systems Overall Volume (2000-2015)
- 9.3 Infusion Systems Average Price (2000-2015)
- 9.4 Infusion Systems Distribution Share (2007-2008)
- 9.5 Infusion Systems, Brazil, Company Share (2006-2007)
- 10 Inhalation Systems In Brazil
- 10.1 Inhalation Systems Overall Revenue (2000-2015)
- 10.2 Inhalation Systems Overall Volume (2000-2015)
- 10.3 Inhalation Systems Average Price (2000-2015)
- 10.4 Inhalation Systems Distribution Share (2007-2008)
- 10.5 Inhalation Systems, Brazil, Company Share (2006-2007)
- 11 Overview of Key Companies in Brazil Drug Delivery Devices Market
- 11.1 AstraZeneca PLC Company Profile
- 11.1.1 Company Overview
- 11.2 Boehringer Ingelheim GmbH Company Profile
- 11.2.1 Company Overview
- 11.2.2 Value Chain Analysis
- 11.2.2.1 Manufacturing
- 11.2.2.2 Product Development
- 11.2.2.3 Sales and Marketing
- 11.3 Baxter International Inc. Company Profile
- 11.3.1 Company Overview
- 11.3.2 Value Chain Analysis
- 11.3.2.1 Manufacturing
- 11.3.2.2 Product Development
- 11.3.2.3 Sales and Marketing
- 11.4 Novartis AG
- 11.4.1 Company Overview
- 11.5 GlaxoSmithKline plc Company Profile
- 11.5.1 Company Overview
- 11.6 Fresenius SE
- 11.6.1 Company Overview
- 11.7 Cardinal Health, Inc. Company Profile
- 11.7.1 Company Overview
- 11.7.2 Value Chain Analysis
- 11.7.2.1 Manufacturing
- 11.7.2.2 Product Development
- 11.7.2.3 Sales and Marketing
- 11.8 Smiths Medical Company Profile
- 11.8.1 Company Overview
- 11.8.2 Value Chain Analysis
- 11.8.2.1 Manufacturing
- 11.8.2.2 Product Development
- 11.8.2.3 Sales and Marketing
- 11.9 Consort Medical plc Company Profile
- 11.9.1 Company Overview
- 11.9.2 Value Chain Analysis
- 11.9.2.1 Manufacturing
- 11.9.2.2 Product Development
- 11.9.2.3 Sales and Marketing
- 11.9.3 Consort Medical plc Pipeline Products
- 11.9.3.1 Consort Medical plc Pipeline Products By Equipment Type
- 11.9.3.2 Consort Medical plc Pipeline Products By Development Stage
- 11.9.3.3 Consort Medical plc Pipeline Products By Therapy Area
- 11.10 B. Braun Melsungen AG Company Profile
- 11.10.1 Company Overview
- 11.10.2 Value Chain Analysis
- 11.10.2.1 Manufacturing
- 11.10.2.2 Product Development
- 11.10.2.3 Research and Development
- 11.10.2.4 Sales and Marketing
- 11.11 Hospira, Inc. Company Profile
- 11.11.1 Company Overview
- 11.11.2 Value Chain Analysis
- 11.11.2.1 Manufacturing
- 11.11.2.2 Product Development
- 11.11.2.3 Research and Development
- 11.11.2.4 Sales and Marketing
- 11.11.3 Hospira, Inc. Pipeline Products
- 11.11.3.1 Hospira, Inc. Pipeline Products by Equipment Type
- 11.11.3.2 Hospira, Inc. Pipeline Products by Development Stage
- 11.11.3.3 Hospira, Inc. Pipeline Products by Therapy Area
- 12 Appendix
- 12.1 Global Markets Direct Research Methodology
- 12.2 Coverage
- 12.3 Secondary Research
- 12.4 Primary Research
- 12.5 Models
- 12.6 Forecasts
- 12.7 Expert Panel Validation
- 12.8 Currency Conversion
- 12.9 Contact Us
- 12.10 Disclaimer
- 1.1 List of Tables
- Table 1: Medical Device Registration Fee in Brazil, 2002 15
- Table 2: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 18
- Table 3: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015 19
- Table 4: Drug Delivery Devices, Brazil, Portfolio Analysis, 2000-2015 20
- Table 5: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Historic, 2000-2008 21
- Table 6: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015 22
- Table 7: Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015 23
- Table 8: Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2008 24
- Table 9: Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2008-2015 25
- Table 10: Drug Delivery Devices, Brazil, Company Share by Revenue ($ mn), 2006-2007 26
- Table 11: Infusion Systems, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 27
- Table 12: Infusion Systems, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 28
- Table 13: Infusion Systems, Brazil, Volume (Units) by Segment, Historic, 2000-2008 29
- Table 14: Infusion Systems, Brazil, Volume (Units) by Segment, Forecast, 2008-2015 29
- Table 15: Infusion Systems, Brazil, Average Price ($), Historic, 2000-2008 30
- Table 16: Infusion Systems, Brazil, Average Price ($), Forecast, 2008-2015 30
- Table 17: Infusion Systems, Brazil, Distribution Share by Revenue ($mn), 2007-2008 31
- Table 18: Infusion Systems, Brazil, Company Share by Revenue ($ mn), 2006-2007 32
- Table 19: Inhalation Systems, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 33
- Table 20: Inhalation Systems, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 34
- Table 21: Inhalation Systems, Brazil, Volume (Units) by Segment, Historic, 2000-2008 35
- Table 22: Inhalation Systems, Brazil, Volume (Units) by Segment, Forecast, 2008-2015 36
- Table 23: Inhalation Systems, Brazil, Average Price ($), Historic, 2000-2008 37
- Table 24: Inhalation Systems, Brazil, Average Price ($), Forecast, 2008-2015 37
- Table 25: Inhalation Systems, Brazil, Distribution Share by Revenue ($mn), 2007-2008 38
- Table 26: Inhalation Systems, Brazil, Company Share by Revenue ($ mn), 2006-2007 39
- Table 27: Consort Medical plc Pipeline Products by Equipment Type 58
- Table 28: Consort Medical plc Pipeline Products By Development Stage 58
- Table 29: Consort Medical plc Pipeline Products By Therapy Area 58
- Table 30: Hospira, Inc. Pipeline Products by Equipment Type 66
- Table 31: Hospira, Inc. Pipeline Products By Development Stage 66
- Table 32: Hospira, Inc. Pipeline Products By Therapy Area 66
- Table 33: USD to Local Currency, Average Exchange Rate 2008
- 1.2 List of Figures
- Figure 1: Health Expenditure by Source in Brazil, 1996
- Figure 2: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
- Figure 3: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015
- Figure 4: Drug Delivery Devices, Brazil, Portfolio Analysis, 2000-2015
- Figure 5: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Historic, 2000-2008
- Figure 6: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015
- Figure 7: Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015
- Figure 8: Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2008
- Figure 9: Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2008-2015
- Figure 10: Drug Delivery Devices, Brazil, Company Share (%), 2007
- Figure 11: Infusion Systems, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
- Figure 12: Infusion Systems, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
- Figure 13: Infusion Systems, Brazil, Company Share (%), 2007
- Figure 14: Inhalation Systems, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
- Figure 15: Inhalation Systems, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
- Figure 16: Inhalation Systems, Brazil, Volume (Units) by Segment, Historic, 2000-2008
- Figure 17: Inhalation Systems, Brazil, Volume (Units) by Segment, Forecast, 2008-2015
- Figure 18: Inhalation Systems, Brazil, Company Share (%), 2007
- Figure 19: Boehringer Ingelheim GmbH Value Chain Analysis
- Figure 20: Baxter International Inc. Value Chain Analysis
- Figure 21: Cardinal Health, Inc. Value Chain Analysis
- Figure 22: Smiths Medical Value Chain Analysis
- Figure 23: Consort Medical plc Value Chain Analysis
- Figure 24: B. Braun Melsungen AG Value Chain Analysis
- Figure 25: Hospira, Inc. Value Chain Analysis
- Figure 26: Global Markets Direct Methodology
AbstractBrazil Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Summary This report is an essential source for in-depth information and data relating to the Brazil drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Brazil
Scope- The report provides drug delivery devices information broken down into detailed categories and segments in Brazil.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy- Gain a strong understanding of the drug delivery devices market in Brazil.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|